Pila Pharma

TRPV1-pathway therapeutics

PILA · Nasdaq First North · Sweden

Public Market Listing

PILANasdaq First North

Nasdaq First North primary exchange listing

Live quotes, historical charts, and market capitalization for Pila Pharma are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
XEN-D0501No recent activity
Phase 2
TRPV1Small molecule
ObesityType 2 Diabetes

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (5 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$0.1M—$1.7M$1.7Mreport ↗
View 4 more years
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$0.1M—$0.4M$1.1Mreport ↗
2023-FY$0.1M—$0.6M$0.9Mreport ↗
2022-FY$0.2M—$0.7M$2.6Mreport ↗
2021-FY$0.1M—$3.1M$2.0Mreport ↗